Global measures of ventricular dyssynchrony (total isovolumic time, P<0.001; difference between ventricular pre-ejection periods, P=0.025) independently predicted clinical response to CRT.
Cohort (n=39)
Do global measures of ventricular dyssynchrony predict clinical response to cardiac resynchronization therapy in patients with heart failure?
Global measures of ventricular dyssynchrony, such as total isovolumic time and the difference between ventricular pre-ejection periods, are independent predictors of clinical response to CRT.
p-value: p=<0.001
AIMS: Cardiac resynchronization therapy (CRT) reduces inter- and intraventricular dyssynchrony and shortens total isovolumic time (t-IVT). We compared the extent to which the values of ventricular dyssynchrony and t-IVT predict clinical benefits of CRT. METHODS AND RESULTS: Ventricular dyssynchrony was assessed in 39 patients with heart failure before and 6 months after CRT. Segmental dyssynchrony was identified from time to onset and peak systolic velocity of wall motion. T-IVT (s/min) was derived as 60-(total ejection time+total filling time). The difference between ventricular pre-ejection periods (D-PEP) was calculated. Outcome measures were fall in New York Heart Association (NYHA) class and increase in cardiac output (CO). Following CRT, NYHA class fell in 29/39 patients, CO increased (by 1.0 L/min, P < 0.001), and intraventricular delay (Intra-VD), interventricular delay (Inter-VD), t-IVT, and D-PEP shortened (by 25 ms, 72 ms, 6 s/min, and 38 ms, P < 0.01). NYHA class and CO were unchanged with CRT in 10/39, and Intra-VD, Inter-VD, t-IVT, and D-PEP lengthened (by 43 ms, 52 ms, 7 s/min, and 35 ms, P < 0.05). Though univariate predictors of CO increment with CRT were Intra-VD, Inter-VD, t-IVT, and D-PEP, only pre-CRT values of CO (P < 0.001), t-IVT (P < 0.001), and D-PEP (P = 0.025) were independent. CONCLUSION: Global, rather than segmental, measures of ventricular dyssynchrony are powerful, independent predictors of clinical response to CRT.
Duncan et al. (Wed,) conducted a cohort in Heart failure (n=39). Cardiac resynchronization therapy (CRT) was evaluated on Fall in New York Heart Association (NYHA) class and increase in cardiac output (CO) (p=<0.001). Global measures of ventricular dyssynchrony (total isovolumic time, P<0.001; difference between ventricular pre-ejection periods, P=0.025) independently predicted clinical response to CRT.